Worg Pharmaceuticals
PrivateLast Round
Series D
Extension
Dec 19, 2025
Total Funding Raised
$280.7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Worg Pharmaceuticals is a biopharmaceutical company that develops next-generation specific immunotherapies for allergic and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Worg Pharmaceuticals Comparables
Compare Worg Pharmaceuticals with similar companies based on industry and business-model similarity.
Worg Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D Extension | Dec 19, 2025 | ||||
| Series D | Nov 20, 2024 | ||||
| Series C | Jul 11, 2023 | ||||
| Series B | Sep 15, 2022 | ||||
| Series A | Jan 18, 2021 |
Worg Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CITIC Securities | Series B |
| Kaitai Capital | Series A, Series B |
| Junson Capital | Series B |
| Lapam Capital | Series B |
| 德同资本 | Series C |
| Mingfeng Capital | Series D Extension |
| PICC Capital Equity Investment Co., Ltd. | Series D, Series D Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 8, 2026
Monthly visitors grew 40% MoM.
- Dec 19, 2025
$42.2M round led by PICC Capital and LongRiver Investments.
Worg Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Worg Pharmaceuticals's valuation, stock price, and market status.
Is Worg Pharmaceuticals a public or private company?
Worg Pharmaceuticals is a private company.
What is the current stock price of Worg Pharmaceuticals?
Worg Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.
How much is Worg Pharmaceuticals worth (valuation)?
Valuation information for Worg Pharmaceuticals is not publicly available.
Can I buy Worg Pharmaceuticals stock?
Worg Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Worg Pharmaceuticals's last funding round?
Worg Pharmaceuticals's most recent funding round was Series D on December 19, 2025.
Who are the main investors in Worg Pharmaceuticals?
Key investors in Worg Pharmaceuticals include LongRiver Investments.
Will Worg Pharmaceuticals IPO soon?
No public IPO plans have been announced for Worg Pharmaceuticals.
How can I track Worg Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Worg Pharmaceuticals's secondary market activity and sign up for updates.